New chemo combo targets liver tumors directly in hard-to-treat colorectal cancer
NCT ID NCT07333053
First seen Jan 12, 2026 · Last updated May 19, 2026 · Updated 19 times
Summary
This study tests a treatment for people with colorectal cancer that cannot be removed by surgery. The approach delivers a strong chemotherapy cocktail (FOLFOX) directly to the liver through a thin tube, combined with a targeted drug like cetuximab or bevacizumab. The goal is to shrink tumors and improve quality of life. About 30 adults who are either new to chemotherapy or still sensitive to it will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
RECRUITINGXicheng, Beijing Municipality, 100053, China
Contact Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.